Spirepoint Private Client LLC Purchases 2,611 Shares of Axon Enterprise, Inc $AXON

Spirepoint Private Client LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 11.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 25,790 shares of the biotechnology company’s stock after buying an additional 2,611 shares during the period. Axon Enterprise accounts for 1.2% of Spirepoint Private Client LLC’s portfolio, making the stock its 21st largest holding. Spirepoint Private Client LLC’s holdings in Axon Enterprise were worth $14,458,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Creative Financial Designs Inc. ADV acquired a new stake in Axon Enterprise in the fourth quarter valued at approximately $28,000. Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth $30,000. AlphaCentric Advisors LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at $34,000. Darwin Wealth Management LLC bought a new position in shares of Axon Enterprise during the 2nd quarter valued at $37,000. Finally, Strive Financial Group LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at $41,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $612.83 on Friday. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The firm has a fifty day simple moving average of $526.06 and a 200-day simple moving average of $474.40. The stock has a market capitalization of $49.79 billion, a price-to-earnings ratio of 254.29, a PEG ratio of 12.50 and a beta of 1.39. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $794.29.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. Axon Enterprise’s revenue was up 35.3% compared to the same quarter last year. During the same period last year, the business posted $2.12 EPS. On average, sell-side analysts expect that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

  • Positive Sentiment: Northland Securities raised several future earnings estimates. The firm lifted its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for Q1–Q4 2027, as well as Q3 2026. The revisions suggest stronger anticipated earnings from Axon’s connected-device, software, AI and public-safety technology businesses.
  • Positive Sentiment: Axon raised its 2026 revenue-growth outlook to 32%–34%. Management cited strong momentum in connected devices, international demand, counter-drone products and AI-enabled software, supported by approximately $15.1 billion in future contracted bookings. Axon Enterprise Is Up 17.8% After Raising 2026 Revenue Outlook
  • Neutral Sentiment: Recent quarterly results exceeded expectations. Second-quarter revenue increased 35.3% year over year to $904.4 million and topped consensus, while adjusted EPS also beat estimates. However, reported net income and diluted EPS declined, highlighting the trade-off between rapid expansion and near-term profitability. The 5 Most Interesting Analyst Questions From Axon’s Q2 Earnings Call
  • Negative Sentiment: Northland reduced its FY2026 EPS forecast to $3.12 from $3.26 and cut its Q4 2026 estimate to $1.29 from $1.55. These downgrades indicate some near-term earnings pressure even though longer-term forecasts improved.
  • Negative Sentiment: Insider selling added pressure. A report attributed a 6.5% decline to recent insider sales, which can raise concerns about valuation or management’s view of near-term upside. Axon Enterprise Trading Down Following Insider Selling
  • Negative Sentiment: Valuation and margins remain risks. With a very high earnings multiple and reported margin contraction, investors may be demanding clearer evidence that revenue growth will translate into sustained profit growth.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on AXON shares. Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a report on Thursday, June 25th. The Goldman Sachs Group restated a “buy” rating and set a $715.00 target price on shares of Axon Enterprise in a report on Thursday, August 6th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. JPMorgan Chase & Co. upped their price target on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Finally, Morgan Stanley increased their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $730.92.

Read Our Latest Report on AXON

Insider Activity at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 564 shares of Axon Enterprise stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $478.97, for a total value of $270,139.08. Following the transaction, the director directly owned 3,632 shares in the company, valued at approximately $1,739,619.04. The trade was a 13.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 13,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the transaction, the president directly owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This represents a 7.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 68,989 shares of company stock valued at $36,016,932. 4.20% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Featured Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.